Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
594 hedge funds and large institutions have $10.3B invested in Exact Sciences in 2024 Q4 according to their latest regulatory filings, with 90 funds opening new positions, 182 increasing their positions, 206 reducing their positions, and 88 closing their positions.
123% more call options, than puts
Call options by funds: $251M | Put options by funds: $112M
2% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 88
0.11% less ownership
Funds ownership: 98.93% → 98.82% (-0.11%)
1% less funds holding
Funds holding: 600 → 594 (-6)
12% less repeat investments, than reductions
Existing positions increased: 182 | Existing positions reduced: 206
17% less capital invested
Capital invested by funds: $12.4B → $10.3B (-$2.16B)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$153M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$106M |
| 3 |
AC
Armistice Capital
New York
|
+$101M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$94.2M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$73.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$141M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$112M |
| 3 |
JP Morgan Chase
New York
|
-$110M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$74.3M |
| 5 |
Holocene Advisors
New York
|
-$60.5M |
EXAS Hedge Fund Activity: Q4 2024 in Review
594 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2024, worth a combined $10.3B — down 17% from $12.4B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new EXAS positions and 88 closed out — a net gain of 2 holders — while 182 added to existing stakes and 206 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $153M. The largest seller was Wellington Management Group, cutting an estimated $141M.
- 594 institutional investors held Exact Sciences (EXAS) as of Q4 2024, down from 600 in Q3 2024.
- Funds reported $10.3B of Exact Sciences stock for Q4 2024, down 17% quarter-over-quarter.
- 90 funds opened new Exact Sciences positions in Q4 2024 and 88 closed out, a net change of +2 holders.
- The largest Exact Sciences buyer in Q4 2024 was T. Rowe Price Associates, an estimated $153M added.
- The largest Exact Sciences seller in Q4 2024 was Wellington Management Group, an estimated $141M sold.
Based on aggregated 13F filings for Q4 2024.